Updated:
GLYKO BIOMEDICAL LTD
GLYKO BIOMEDICAL LTD is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000908401, and its reported industry is...
Overview
GLYKO BIOMEDICAL LTD is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000908401, and its reported industry is In Vitro & In Vivo Diagnostic Substances. The retained history contains 12 filings, including 8-K filed on 2002-08-22. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.
Company overview
- Legal name
- GLYKO BIOMEDICAL LTD
- Classification
- Company
- Industry (SIC)
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Novato, CA, United States
- Fiscal year end
- December 31
- SEC CIK
- 0000908401
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | GBL 10Q JUNE 30, 2002 | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | GBL 10-Q 03/31/02 | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-K | BODY OF 10-K FOR GBL 12/31/01 | ||
| 8-K | 8-K | ||
| SC 13G | — | SCHEDULE 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research GLYKO BIOMEDICAL LTD in Altss
Track this company’s investors, transactions and relationships in Altss.